Medicare Enrolled

Dr. Michael Pavlica, MD

Ophthalmology · Lancaster, PA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Research-focused
2110 HARRISBURG PIKE, Lancaster, PA 17601
7172999232
In practice since 2006 (20 years)
NPI: 1699735613 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pavlica from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pavlica? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pavlica

Dr. Michael Pavlica is an ophthalmology specialist in Lancaster, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Pavlica performed 6,193 Medicare services across 3,536 unique beneficiaries.

Between the years covered by Open Payments, Dr. Pavlica received a total of $7,510 from 27 pharmaceutical and/or device companies across 98 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are classified as research and scientific activities (grants and research funding). Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pavlica is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 14% volume in PA $7,510 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,193
Medicare services
Top 14% in PA for ophthalmology
3,536
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~310 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
1,128 $27 $100
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
922 $58 $130
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
739 $80 $500
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
635 $79 $180
Compounded drug, not otherwise classified
A medication prepared specifically for an individual patient by a pharmacist or physician, tailored to meet unique needs that cannot be fulfilled by commercially available products.
615 $65 $106
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
517 $24 $100
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
371 $39 $178
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
282 $22 $100
Aflibercept eye injection (Eylea) 218 $656 $1,105
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
126 $60 $95
Eye drainage system examination
An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye.
110 $19 $55
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
90 $88 $135
Retinal laser destruction of growth
A laser procedure used to destroy abnormal growths in the retina.
78 $372 $1,300
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
75 $100 $205
Laser repair to improve eye fluid flow
A laser procedure used to enhance the drainage of fluid within the eye.
71 $180 $1,250
Laser removal of recurring cataract
A laser procedure to remove a recurring cataract within the lens capsule.
59 $245 $850
Ultrasound scan of cornea to determine thickness
An ultrasound procedure used to measure the thickness of the cornea.
59 $6 $25
Laser eye fluid drainage tract creation
A laser procedure used to create drainage tracts in the iris to help fluid flow out of the eye.
48 $211 $1,250
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
31 $33 $246
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
19 $15 $40
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,510
Total received (2018-2024)
Avg $1,073/year across 7 years
Top 14% in PA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
98
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Scientific / Research
Research funding and grants
$4,800 (63.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,679 (35.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$30 (0.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$759
2023
$462
2022
$482
2021
$62
2020
$82
2019
$1,694
2018
$3,968

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Apellis Pharmaceuticals, Inc.
$227
Regeneron Healthcare Solutions, Inc.
$147
ABBVIE INC.
$117
Alcon Vision LLC
$75
Thea Pharma Inc.
$47
Oyster Point Pharma, Inc.
$41
Tarsus Pharmaceuticals, Inc.
$30
Bausch & Lomb Americas Inc.
$30
Ocular Therapeutix, Inc.
$15
BIOTISSUE HOLDINGS INC.
$15
SUN PHARMACEUTICAL INDUSTRIES INC.
$15
Top 3 companies account for 64.7% of 2024 payments
All-time payments by company (2018-2024) ›
Regeneron Pharmaceuticals, Inc.
$4,800
Regeneron Healthcare Solutions, Inc.
$421
Bausch & Lomb, a division of Bausch Health US, LLC
$304
ABBVIE INC.
$284
Apellis Pharmaceuticals, Inc.
$253
Alcon Vision LLC
$236
Oyster Point Pharma, Inc.
$159
Dutch Ophthalmic, USA
$154
Novartis Pharmaceuticals Corporation
$151
Bausch & Lomb Americas Inc.
$131
Sun Pharmaceutical Industries Inc.
$85
Heidelberg Engineering, Inc.
$80
Horizon Therapeutics plc
$76
Sight Sciences, Inc.
$70
Thea Pharma Inc.
$47
Alimera Sciences, Inc.
$42
Ocular Therapeutix, Inc.
$34
Tarsus Pharmaceuticals, Inc.
$30
Genentech USA, Inc.
$20
Astellas Pharma US Inc
$20
Carl Zeiss Meditec AG
$19
Shire North American Group Inc
$19
Mallinckrodt LLC
$16
Allergan, Inc.
$16
BIOTISSUE HOLDINGS INC.
$15
SUN PHARMACEUTICAL INDUSTRIES INC.
$15
Aerie Pharmaceuticals, Inc.
$12
Top 3 companies account for 73.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ALPHAGAN P · AMVISC PLUS · ARGOS · BTOD · Cequa · DEXTENZA · DURYSTA · ENVISTA TORIC · EVA Ophthalmic Surgical System · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · ILUVIEN · IYUZEH · LUMIGAN · None Specified · OMNI(R) SURGICAL SYSTEM (US) · OZURDEX · Rhopressa · Rocklatan · SIMBRINZA · Simbrinza · Spectralis · Syfovre · TEPEZZA · TRAVATAN Z · TYRVAYA · VUITY · VYZULTA · Vabysmo · XDEMVY · XELPROS · XIIDRA · XIPERE · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (64%) are classified as scientific/research, suggesting involvement in clinical studies, grants, or innovation-related work.

Looking for an ophthalmology specialist in Lancaster?
Compare ophthalmologists in the Lancaster area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
77
Per 100K population
13.9
County median income
$83,703
Nearest hospital
PENN STATE HEALTH LANCASTER MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Pavlica is a mixed practice specialist, with above-average Medicare volume (top 14% in PA), with research-focused industry engagement in the top 14% of PA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Pavlica experienced with retinal imaging (oct scan)?
Based on Medicare claims data, Dr. Pavlica performed 1,128 retinal imaging (oct scan) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pavlica receive payments from pharmaceutical companies?
Yes. Dr. Pavlica received a total of $7,510 from 27 companies across 98 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pavlica's costs compare to other ophthalmologists in Lancaster?
Dr. Pavlica's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pavlica) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →